14-13　ⓔ文献

  1. Schreiner GE: Toxic nephropathy: adverse renal effects caused by drugs and chemicals. JAMA, 1965; 191: 849–850.

  2. Praga M, Gonzalez E: Acute interstitial nephritis. Kidney Int, 2010; 77: 956–961.

  3. 日本腎臓学会，日本医学放射線学会，他：腎障害患者におけるヨード造影剤使用に関するガイドライン2018，東京医学社，2018.

  4. Baraldi A, Ballestri M, et al: Acute renal failure of medical type in an elderly population. Nephrol Dial, Transplant, 1998; 13: 25–29.

  5. Baker RJ, Pusey CD: The changing profile of acute tubulointerstitial nephritis. Nephrol, Dial Transplant, 2004; 19: 8–11.

  6. Toso A, Maioli M, et al: Usefulness of atorvastatin (80 mg) in prevention of contrast–induced nephropathy in patients with chronic renal disease. Am J Cardiol, 2010; 105: 288–292.

  7. Olyaei AJ, de Mattos AM, et al: Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies. Cur Opin Crit Care, 2001; 7: 384–389.

  8. Whelton A: Nephrotoxicity of nonsteroidal anti–inflammatory drugs: physiologic foundations and clinical implications. Am J Med, 1999; 106: 13S–24S.

  9. Patzer L: Nephrotoxicity as a cause of acute kidney injury in children. Pediat Nephrol, 2008; 23: 2159–2173.

  10. Sabath E, Robles–Osorio ML: Renal health and the environment: heavy metal nephrotoxicity. Nefrologia, 2012; 32: 279–286.

  11. Hall AM, Bass P, et al: Drug–induced renal Fanconi syndrome. QJM, 2014; 107: 261–269.

  12. Tsai TT, Patel UD, et al: Validated contemporary risk model of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the National Cardiovascular Data Registry Cath PCI Registry. J Am Heart Associat, 2014; 3: e001380–e001380.

  13. Akimoto T, Horikoshi R, et al: Low–dose corticosteroid and gallium–67 scintigraphy and acute interstitial nephritis. Saudi J Kidney Dis Transpl, 2014; 25: 864–868.